Search details
1.
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.
N Engl J Med
; 387(3): 237-247, 2022 07 21.
Article
in English
| MEDLINE | ID: mdl-35857660
2.
Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
Haemophilia
; 28(3): 515-519, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35279922
3.
Dosing for Personalized Prophylaxis in Hemophilia A Highly Varies on the Underlying Population Pharmacokinetic Models.
Ther Drug Monit
; 44(5): 665-673, 2022 10 01.
Article
in English
| MEDLINE | ID: mdl-35358115
4.
The effect of SARS-Co-V2 infection on prothrombotic and anticoagulant factors in dialysis patients.
Artif Organs
; 46(7): 1328-1333, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35167146
5.
Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey.
Haemophilia
; 27(3): 490-499, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33650732
6.
Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single-centre experience.
Haemophilia
; 27(3): 425-433, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33749973
7.
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.
Haemophilia
; 27(6): 932-937, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34403546
8.
Clinical utility of sample preheat treatment in a modified Nijmegen-Bethesda assay (mNBA) for inhibitor monitoring in congenital and acquired haemophilia A: A single-centre four-year experience.
Haemophilia
; 26(6): e300-e307, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32892451
9.
Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
Haemophilia
; 26(1): 6-16, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31846168
10.
Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
Haemophilia
; 26(1): 151-155, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31859415
11.
Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology.
Br J Haematol
; 204(5): 1714-1731, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38532595
12.
Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
N Engl J Med
; 371(21): 1994-2004, 2014 Nov 20.
Article
in English
| MEDLINE | ID: mdl-25409372
13.
Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.
Br J Haematol
; 168(5): 719-27, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25351814
14.
Monitoring of heparin anticoagulation during complex aortic endovascular surgery.
J Vasc Surg
; 71(4): 1453-1454, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32204846
15.
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.
N Engl J Med
; 365(25): 2357-65, 2011 Dec 22.
Article
in English
| MEDLINE | ID: mdl-22149959
16.
O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions.
Blood
; 120(1): 214-22, 2012 Jul 05.
Article
in English
| MEDLINE | ID: mdl-22517896
17.
Hemostasis in patients with acute kidney injury secondary to acute liver failure.
Kidney Int
; 84(1): 158-63, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23515053
18.
Increased risk of dialysis circuit clotting in hemodialysis patients with COVID-19 is associated with elevated FVIII, fibrinogen and D-dimers.
Hemodial Int
; 27(1): 38-44, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36081392
19.
Differences in wild-type- and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepancies.
Blood Adv
; 7(3): 458-467, 2023 02 14.
Article
in English
| MEDLINE | ID: mdl-35839077
20.
Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial.
J Clin Med
; 12(18)2023 Sep 08.
Article
in English
| MEDLINE | ID: mdl-37762789